Trial Profile
A retropective study to assess the onset of pregnancy for patients exposed to delayed-release dimethyl fumarate (DMF) or peginterferon beta-1a (PEG) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2018
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Peginterferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 29 Oct 2018 New trial record
- 12 Oct 2018 Results presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis